CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Guangzhou Baiyunshan Phrmcl Hldgs Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Guangzhou Baiyunshan Phrmcl Hldgs Co Ltd
No. 45 Shamian North Street
Liwan District
Phone: +86 2066281218p:+86 2066281218 GUANGZHOU, GNG  510130  China Ticker: 600332600332
Business Summary
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is a China-based company primarily engaged in the business of pharmaceutical and health. The Company operates through five segments. Modern Chinese Medicine segment engages in the research and development, manufacturing and sales of proprietary Chinese medicines and natural medicines. Chemical Pharmaceutical Technology segment engages in the research and development, manufacturing, and sales of chemical drugs, chemical active pharmaceutical ingredients, and chemical intermediates. Natural Beverages segment engages in research and development, production, and sales of health-oriented products. Pharmaceutical Commerce segment engages in the wholesale, retail, and import/export of Western medicines, Chinese medicines, and medical devices. The Other segment primarily includes biotechnology innovation, consumer health, and medical services businesses. The Company mainly operates its businesses in the domestic and overseas markets.
(Source: PROSPECTUS)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/202612/31/2025YesYes---

Industries
SIC Code Description
5122 Drugs, drug proprietaries, and druggists' sundries
5912 Drug stores and proprietary stores
2833 Medicinal chemicals and botanical products
2834 Pharmaceutical preparations
8731 Commercial physical and biological research
2086 Bottled and canned soft drinks and carbonated waters
5047 Medical, dental, and hospital equipment and supplies

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive Chairman of the Board XiaojunLi 54 1/21/2025 1/21/2025
Executive Vice Chairman of the Board JiehuiChen 51 9/26/2025 9/26/2025
Chief Financial Officer FeiLiu 49 3/15/2024 3/15/2024
11 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Guangzhou Baiyunshan Pharmaceutical Co. 88 Yuxiang Rd, Tonghe,, Baiyun Guangzhou GNG China

Business Names
Business Name
0874
600332
874
5 additional Business Names available in full report.

General Information
Number of Employees: 27,057 (As of 12/31/2025)
Outstanding Shares: 1,625,790,949 (As of 3/31/2026)
Shareholders: 94,754
Stock Exchange: SHA
Fax Number: +86 2066281229


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, September 16, 2026